List of Contents

Molecular Diagnostics Market Size, Share, and Trends 2024 to 2033

Molecular Diagnostics Market (By Product: Instruments, Reagents, Services & Software; By Test Location: Central laboratories, Point of care, Over the counter or self-test kits; By Technology: Polymerase Chain Reaction, Isothermal Nucleic Acid Amplification Technology, DNA Sequencing & Next- generation Sequencing, In Situ Hybridization, DNA Microarrays, Others; By Application; By End User) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2024-2033

  • Last Updated : January 2024
  • Report Code : 2257
  • Category : Healthcare

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Molecular Diagnostics Market 

5.1. COVID-19 Landscape: Molecular Diagnostics Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Molecular Diagnostics Market, By Product

8.1. Molecular Diagnostics Market, by Product, 2024-2033

8.1.1. Instruments

8.1.1.1. Market Revenue and Forecast (2021-2033)

8.1.2. Reagents

8.1.2.1. Market Revenue and Forecast (2021-2033)

8.1.3. Services & Software

8.1.3.1. Market Revenue and Forecast (2021-2033)

Chapter 9. Global Molecular Diagnostics Market, By Test Location

9.1. Molecular Diagnostics Market, by Test Location, 2024-2033

9.1.1. Central laboratories

9.1.1.1. Market Revenue and Forecast (2021-2033)

9.1.2. Point of care

9.1.2.1. Market Revenue and Forecast (2021-2033)

9.1.3. Over the counter or self-test kits

9.1.3.1. Market Revenue and Forecast (2021-2033)

Chapter 10. Global Molecular Diagnostics Market, By Technology 

10.1. Molecular Diagnostics Market, by Technology, 2024-2033

10.1.1. Polymerase Chain Reaction (PCR)

10.1.1.1. Market Revenue and Forecast (2021-2033)

10.1.2. Isothermal Nucleic Acid Amplification Technology (INAAT)

10.1.2.1. Market Revenue and Forecast (2021-2033)

10.1.3. DNA Sequencing & Next- generation Sequencing (NGS)

10.1.3.1. Market Revenue and Forecast (2021-2033)

10.1.4. In Situ Hybridization (ISH)

10.1.4.1. Market Revenue and Forecast (2021-2033)

10.1.5. DNA Microarrays

10.1.5.1. Market Revenue and Forecast (2021-2033)

10.1.6. Others

10.1.6.1. Market Revenue and Forecast (2021-2033)

Chapter 11. Global Molecular Diagnostics Market, By Application

11.1. Molecular Diagnostics Market, by Application, 2024-2033

11.1.1. Infectious diseases

11.1.1.1. Market Revenue and Forecast (2021-2033)

11.1.2. Oncology

11.1.2.1. Market Revenue and Forecast (2021-2033)

11.1.3. Genetic testing

11.1.3.1. Market Revenue and Forecast (2021-2033)

11.1.4. Neurological disease

11.1.4.1. Market Revenue and Forecast (2021-2033)

11.1.5. Microbiology

11.1.5.1. Market Revenue and Forecast (2021-2033)

Chapter 12. Global Molecular Diagnostics Market, By End User

12.1. Molecular Diagnostics Market, by End User, 2024-2033

12.1.1. Diagnostic Laboratories

12.1.1.1. Market Revenue and Forecast (2021-2033)

12.1.2. Hospitals & Clinics

12.1.2.1. Market Revenue and Forecast (2021-2033)

12.1.3. Others

12.1.3.1. Market Revenue and Forecast (2021-2033)

Chapter 13. Global Molecular Diagnostics Market, Regional Estimates and Trend Forecast

13.1. North America

13.1.1. Market Revenue and Forecast, by Product (2021-2033)

13.1.2. Market Revenue and Forecast, by Test Location (2021-2033)

13.1.3. Market Revenue and Forecast, by Technology (2021-2033)

13.1.4. Market Revenue and Forecast, by Application (2021-2033)

13.1.5. Market Revenue and Forecast, by End User (2021-2033)

13.1.6. U.S.

13.1.6.1. Market Revenue and Forecast, by Product (2021-2033)

13.1.6.2. Market Revenue and Forecast, by Test Location (2021-2033)

13.1.6.3. Market Revenue and Forecast, by Technology (2021-2033)

13.1.6.4. Market Revenue and Forecast, by Application (2021-2033)

13.1.6.5. Market Revenue and Forecast, by End User (2021-2033) 

13.1.7. Rest of North America

13.1.7.1. Market Revenue and Forecast, by Product (2021-2033)

13.1.7.2. Market Revenue and Forecast, by Test Location (2021-2033)

13.1.7.3. Market Revenue and Forecast, by Technology (2021-2033)

13.1.7.4. Market Revenue and Forecast, by Application (2021-2033)

13.1.7.5. Market Revenue and Forecast, by End User (2021-2033)

13.2. Europe

13.2.1. Market Revenue and Forecast, by Product (2021-2033)

13.2.2. Market Revenue and Forecast, by Test Location (2021-2033)

13.2.3. Market Revenue and Forecast, by Technology (2021-2033)

13.2.4. Market Revenue and Forecast, by Application (2021-2033) 

13.2.5. Market Revenue and Forecast, by End User (2021-2033) 

13.2.6. UK

13.2.6.1. Market Revenue and Forecast, by Product (2021-2033)

13.2.6.2. Market Revenue and Forecast, by Test Location (2021-2033)

13.2.6.3. Market Revenue and Forecast, by Technology (2021-2033)

13.2.7. Market Revenue and Forecast, by Application (2021-2033) 

13.2.8. Market Revenue and Forecast, by End User (2021-2033) 

13.2.9. Germany

13.2.9.1. Market Revenue and Forecast, by Product (2021-2033)

13.2.9.2. Market Revenue and Forecast, by Test Location (2021-2033)

13.2.9.3. Market Revenue and Forecast, by Technology (2021-2033)

13.2.10. Market Revenue and Forecast, by Application (2021-2033)

13.2.11. Market Revenue and Forecast, by End User (2021-2033)

13.2.12. France

13.2.12.1. Market Revenue and Forecast, by Product (2021-2033)

13.2.12.2. Market Revenue and Forecast, by Test Location (2021-2033)

13.2.12.3. Market Revenue and Forecast, by Technology (2021-2033)

13.2.12.4. Market Revenue and Forecast, by Application (2021-2033)

13.2.13. Market Revenue and Forecast, by End User (2021-2033)

13.2.14. Rest of Europe

13.2.14.1. Market Revenue and Forecast, by Product (2021-2033)

13.2.14.2. Market Revenue and Forecast, by Test Location (2021-2033)

13.2.14.3. Market Revenue and Forecast, by Technology (2021-2033)

13.2.14.4. Market Revenue and Forecast, by Application (2021-2033)

13.2.15. Market Revenue and Forecast, by End User (2021-2033)

13.3. APAC

13.3.1. Market Revenue and Forecast, by Product (2021-2033)

13.3.2. Market Revenue and Forecast, by Test Location (2021-2033)

13.3.3. Market Revenue and Forecast, by Technology (2021-2033)

13.3.4. Market Revenue and Forecast, by Application (2021-2033)

13.3.5. Market Revenue and Forecast, by End User (2021-2033)

13.3.6. India

13.3.6.1. Market Revenue and Forecast, by Product (2021-2033)

13.3.6.2. Market Revenue and Forecast, by Test Location (2021-2033)

13.3.6.3. Market Revenue and Forecast, by Technology (2021-2033)

13.3.6.4. Market Revenue and Forecast, by Application (2021-2033)

13.3.7. Market Revenue and Forecast, by End User (2021-2033)

13.3.8. China

13.3.8.1. Market Revenue and Forecast, by Product (2021-2033)

13.3.8.2. Market Revenue and Forecast, by Test Location (2021-2033)

13.3.8.3. Market Revenue and Forecast, by Technology (2021-2033)

13.3.8.4. Market Revenue and Forecast, by Application (2021-2033)

13.3.9. Market Revenue and Forecast, by End User (2021-2033)

13.3.10. Japan

13.3.10.1. Market Revenue and Forecast, by Product (2021-2033)

13.3.10.2. Market Revenue and Forecast, by Test Location (2021-2033)

13.3.10.3. Market Revenue and Forecast, by Technology (2021-2033)

13.3.10.4. Market Revenue and Forecast, by Application (2021-2033)

13.3.10.5. Market Revenue and Forecast, by End User (2021-2033)

13.3.11. Rest of APAC

13.3.11.1. Market Revenue and Forecast, by Product (2021-2033)

13.3.11.2. Market Revenue and Forecast, by Test Location (2021-2033)

13.3.11.3. Market Revenue and Forecast, by Technology (2021-2033)

13.3.11.4. Market Revenue and Forecast, by Application (2021-2033)

13.3.11.5. Market Revenue and Forecast, by End User (2021-2033)

13.4. MEA

13.4.1. Market Revenue and Forecast, by Product (2021-2033)

13.4.2. Market Revenue and Forecast, by Test Location (2021-2033)

13.4.3. Market Revenue and Forecast, by Technology (2021-2033)

13.4.4. Market Revenue and Forecast, by Application (2021-2033)

13.4.5. Market Revenue and Forecast, by End User (2021-2033)

13.4.6. GCC

13.4.6.1. Market Revenue and Forecast, by Product (2021-2033)

13.4.6.2. Market Revenue and Forecast, by Test Location (2021-2033)

13.4.6.3. Market Revenue and Forecast, by Technology (2021-2033)

13.4.6.4. Market Revenue and Forecast, by Application (2021-2033)

13.4.7. Market Revenue and Forecast, by End User (2021-2033)

13.4.8. North Africa

13.4.8.1. Market Revenue and Forecast, by Product (2021-2033)

13.4.8.2. Market Revenue and Forecast, by Test Location (2021-2033)

13.4.8.3. Market Revenue and Forecast, by Technology (2021-2033)

13.4.8.4. Market Revenue and Forecast, by Application (2021-2033)

13.4.9. Market Revenue and Forecast, by End User (2021-2033)

13.4.10. South Africa

13.4.10.1. Market Revenue and Forecast, by Product (2021-2033)

13.4.10.2. Market Revenue and Forecast, by Test Location (2021-2033)

13.4.10.3. Market Revenue and Forecast, by Technology (2021-2033)

13.4.10.4. Market Revenue and Forecast, by Application (2021-2033)

13.4.10.5. Market Revenue and Forecast, by End User (2021-2033)

13.4.11. Rest of MEA

13.4.11.1. Market Revenue and Forecast, by Product (2021-2033)

13.4.11.2. Market Revenue and Forecast, by Test Location (2021-2033)

13.4.11.3. Market Revenue and Forecast, by Technology (2021-2033)

13.4.11.4. Market Revenue and Forecast, by Application (2021-2033)

13.4.11.5. Market Revenue and Forecast, by End User (2021-2033)

13.5. Latin America

13.5.1. Market Revenue and Forecast, by Product (2021-2033)

13.5.2. Market Revenue and Forecast, by Test Location (2021-2033)

13.5.3. Market Revenue and Forecast, by Technology (2021-2033)

13.5.4. Market Revenue and Forecast, by Application (2021-2033)

13.5.5. Market Revenue and Forecast, by End User (2021-2033)

13.5.6. Brazil

13.5.6.1. Market Revenue and Forecast, by Product (2021-2033)

13.5.6.2. Market Revenue and Forecast, by Test Location (2021-2033)

13.5.6.3. Market Revenue and Forecast, by Technology (2021-2033)

13.5.6.4. Market Revenue and Forecast, by Application (2021-2033)

13.5.7. Market Revenue and Forecast, by End User (2021-2033)

13.5.8. Rest of LATAM

13.5.8.1. Market Revenue and Forecast, by Product (2021-2033)

13.5.8.2. Market Revenue and Forecast, by Test Location (2021-2033)

13.5.8.3. Market Revenue and Forecast, by Technology (2021-2033)

13.5.8.4. Market Revenue and Forecast, by Application (2021-2033)

13.5.8.5. Market Revenue and Forecast, by End User (2021-2033)

Chapter 14. Company Profiles

14.1. Siemens Healthineers AG (Germany)

14.1.1. Company Overview

14.1.2. Product Offerings

14.1.3. Financial Performance

14.1.4. Recent Initiatives

14.2. Quidel Corporation (US)

14.2.1. Company Overview

14.2.2. Product Offerings

14.2.3. Financial Performance

14.2.4. Recent Initiatives

14.3. F. Hoffmann-La Roche Ltd. (Switzerland)

14.3.1. Company Overview

14.3.2. Product Offerings

14.3.3. Financial Performance

14.3.4. Recent Initiatives

14.4. Hologic, Inc. (US)

14.4.1. Company Overview

14.4.2. Product Offerings

14.4.3. Financial Performance

14.4.4. Recent Initiatives

14.5. Thermo Fisher Scientific, Inc. (US)

14.5.1. Company Overview

14.5.2. Product Offerings

14.5.3. Financial Performance

14.5.4. Recent Initiatives

14.6. Danaher Corporation (US)

14.6.1. Company Overview

14.6.2. Product Offerings

14.6.3. Financial Performance

14.6.4. Recent Initiatives

14.7. Illumina, Inc. (US)

14.7.1. Company Overview

14.7.2. Product Offerings

14.7.3. Financial Performance

14.7.4. Recent Initiatives

14.8. Becton, Dickinson and Company (US)

14.8.1. Company Overview

14.8.2. Product Offerings

14.8.3. Financial Performance

14.8.4. Recent Initiatives

14.9. Grifols, S.A. (Spain)

14.9.1. Company Overview

14.9.2. Product Offerings

14.9.3. Financial Performance

14.9.4. Recent Initiatives

14.10. PerkinElmer, Inc. (US)

14.10.1. Company Overview

14.10.2. Product Offerings

14.10.3. Financial Performance

14.10.4. Recent Initiatives

Chapter 15. Research Methodology

15.1. Primary Research

15.2. Secondary Research

15.3. Assumptions

Chapter 16. Appendix

16.1. About Us

 

16.2. Glossary of Terms

Proceed To Buy

USD 4900
USD 3800
USD 2100
USD 2100
USD 7500
Immediate Delivery Available

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client

down-arrow-imgGet a Sample

Connect with us now; your solution awaits on the other side!

Contact Us